Shares of AngioDynamics (ANGO) have gained 26.5% over the past four weeks to close the last trading session at $7.65, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.33 indicates a potential upside of 74.3%.The average comprises three short-term price targets ranging from a low of $13 to a high of $14, with a standard deviation of $0.58. While the lowest estimate indicates a ...